Envestnet Asset Management
DRTS icon

Envestnet Asset Management’s Alpha Tau Medical DRTS Stock Holding History

Envestnet Asset Management’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,765
Closed -$62.1K – 4515
2025
Q3 		$62.1K Buy
+13,765
New +$46.9K ﹤0.01% 4467

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Envestnet Asset Management's DRTS Position: Q4 2025 in Review

Envestnet Asset Management sold out of Alpha Tau Medical (DRTS) in Q4 2025, closing a stake of 13,765 shares — an estimated $62.1K sold.

Envestnet Asset Management first reported a position in DRTS in Q3 2025 and held it in 1 quarter. The position peaked at $62.1K in Q3 2025. 35 funds tracked by Wall St. Rank hold DRTS as of Q4 2025.

  • Envestnet Asset Management reported no remaining Alpha Tau Medical position as of Q4 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 13,765 Alpha Tau Medical shares in Q4 2025, an estimated $62.1K.
  • Envestnet Asset Management first reported a position in Alpha Tau Medical in Q3 2025 and held it in 1 quarter.
  • Envestnet Asset Management's Alpha Tau Medical position peaked at $62.1K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q4 2025.

Based on Envestnet Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.